A phase II study of maintenance therapy with temsirolimus (TEM) after response to first-line docetaxel (TAX) chemotherapy in castration-resistant prostate cancer (CRPC)

被引：3

作者：

Emmenegger, U.

Sridhar, S. S.

Booth, C. M.

Kerbel, R.

Berry, S. R.

Ko, Y.

机构：

[1] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada

[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[3] Queens Univ, Canc Res Inst, Kingston, ON, Canada

[4] Univ Toronto, Sunnybrook Res Inst, Dept Mol & Cellular Biol, Toronto, ON, Canada

[5] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada

来源：

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.tps246

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS246

引用

页数：1